Today: 29 April 2026
Tesla stock steadies after Musk’s $2 billion xAI bet and a $20 billion spending jolt
29 January 2026
1 min read

Tesla stock steadies after Musk’s $2 billion xAI bet and a $20 billion spending jolt

NEW YORK, Jan 29, 2026, 09:38 EST — Regular session

  • Tesla shares barely moved in early trading, following swings triggered by earnings and spending plans.
  • Investors are balancing Tesla’s move into robotaxis and robotics with a weaker core EV market.
  • Attention is turning to cash burn, regulatory challenges, and upcoming rollout targets.

Tesla shares edged up 0.07% to $431.46 in early Thursday trading, following a close of $431.16 the previous day.

The stock’s recent jump comes amid a flurry of headlines: a new investment linked to Elon Musk’s AI goals, plus a steep increase in planned expenditures.

Here’s why it matters now: Tesla’s market value hinges largely on its bets on autonomy and robotics. That’s despite growing challenges in its car segment, where demand is cooling, prices are under pressure, and rivals are closing in.

Tesla announced a roughly $2 billion investment in xAI, the AI firm started by Musk, while reaffirming that its Cybercab robotaxi production remains on schedule. Thomas Monteiro, senior analyst at Investing.com, described Tesla as “entering a transition phase,” noting that “rollout metrics” now carry more weight than vehicle delivery numbers. Reuters

During the earnings call, Tesla’s ramped-up spending plans stood out. Musk described it as “a very big capex year,” referring to capital expenditures—funds allocated to factories and equipment—as the company expands production lines for the Cybercab, the Optimus humanoid robot, and other ventures. Scott Acheychek, COO of REX Financial, pointed to a “business model transition now underway” as the bigger story. Reuters

The steep rise in spending dampened the early rally. Tesla shares gained roughly 3.5% in after-hours trading following the earnings release, only to pull back as investors weighed the costs. On Thursday, Tesla’s shares listed in Frankfurt climbed 1.8%.

Tesla filed its annual report and an 8-K on Wednesday, company documents reveal, offering investors fresh details on the AI initiatives and financing strategy.

There’s still plenty that could derail progress. Regulators haven’t approved fully driverless cars for wide use, and Tesla is wagering big on tech that hasn’t been tested at scale. Missed deadlines or a sudden need for more funding could easily weigh on the stock again.

Tesla’s next milestones are near. In its quarterly update, the company reported 2025 revenue dipped 3% to $94.83 billion. It closed the year with $44.06 billion in cash, cash equivalents, and investments. Tesla expects its xAI investment to wrap up in Q1 2026 and plans to launch a Gen 3 Optimus in the same quarter. Production for Cybercab and Tesla Semi is set to start in the first half of 2026.

Stock Market Today

  • Ceres Power Surges Past Rolls-Royce, Nvidia, BP in FTSE 250 Rally
    April 29, 2026, 9:27 AM EDT. Ceres Power (LSE:CWR) leads the FTSE 250 stock gains in 2026 with a staggering 176% rise year-to-date, far outpacing Rolls-Royce, Nvidia and BP. The clean energy tech firm, specializing in licensing advanced solid oxide fuel cell and hydrogen technology, posted a remarkable 933% gain over the last year. Despite declining revenues - £32.6 million in 2025 down from £51.9 million the previous year - and no expected profits in 2026 or 2027, investor enthusiasm is fueled by the AI-driven data center boom. Its recent collaboration with Centrica aims to deploy efficient on-site power solutions swiftly for AI hubs and logistics centers. This positions Ceres as a crucial 'picks and shovels' provider amid the AI energy surge. However, over five years, the stock remains down 55%, prompting debate on its current valuation.

Latest article

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

Visa Stock Jumps as Earnings Beat and $20 Billion Buyback Ease Spending Fears

29 April 2026
Visa shares jumped 5% premarket Wednesday after the company beat quarterly profit estimates, raised its full-year outlook, and announced a $20 billion buyback. Adjusted net income rose to $6.3 billion, or $3.31 a share, topping forecasts. Payments volume climbed 9%, cross-border volume 12%. Visa cited resilient consumer spending but flagged Middle East tensions as a risk to travel flows.
Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

Regeneron Earnings Beat, But Eylea Still Clouds REGN Stock

29 April 2026
Regeneron Pharmaceuticals reported first-quarter revenue of $3.605 billion, up 19%, and adjusted earnings of $9.47 per share, both above analyst estimates. Dupixent sales rose 33% and Libtayo 54%, while total U.S. Eylea sales fell 10%. Shares dropped 1.1% premarket. The FDA delayed a decision on a second Eylea HD syringe manufacturer; Regeneron cut its 2026 gross-margin forecast due to repairs in Ireland.
Intel stock dips before the bell after report ties Nvidia, Apple to future chip work
Previous Story

Intel stock dips before the bell after report ties Nvidia, Apple to future chip work

Bitcoin tumbles below $87,000 as Fed pause and ETF outflows keep crypto on the back foot
Next Story

Bitcoin tumbles below $87,000 as Fed pause and ETF outflows keep crypto on the back foot

Go toTop